🇺🇸 FDA
Patent

US 6054486

Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease

expired A61KA61K31/557A61K31/5575

Quick answer

US patent 6054486 (Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease) held by UNITED TECHNOLOGY CORPORATION expires Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
UNITED TECHNOLOGY CORPORATION
Grant date
Tue Apr 25 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 20 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/557, A61K31/5575, A61P, A61P1/04